Diagnostic capabilities of devices for cardiac resynchronization therapy

Journal of Cardiovascular Medicine

Volumn 11, Issue 3, 2010, Pages 186-189

  Gardini, Armando ^a   Lupo, Pierpaolo ^b   Zanelli, Emanuela ^c   Bisetti, Silvia ^d   Cappato, Riccardo ^b  

^a Arrhythmia and Electrophysiology Centre   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS   (Italy)

^d Medtronic Italia   (Italy)

Author keywords

Atrial fibrillation; Cardiac resynchronization therapy; Heart failure

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE VARIABILITY; HEART RHYTHM; HUMAN; IMPLANT; MALE;

EID: 76449090685     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283303036     Document Type: Article

References (21)

1. Van Den Berg MP, Tuinenburg AE, Crijns HJGM, Van Gelder IC, Gosselink AT, Lie KI. Heart failure and atrial fibrillation: current concepts and controversies. Heart 1997; 77:309-313.
2. Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression and determinants based on the atrial high rate trial. PACE 2007; 30:404-411.
3. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Report of the atrial diagnostic ancillary study of the Mode Selection Trial (MOST). Circulation 2003; 107:1614-1619.
4. Germany R, Murray C. Use of device diagnostics in the outpatient management of heart failure. Am J Cardiol 2007; 99 (Suppl):11G-16G.
5. Vollmann D, Nagele H, Schauerte P, Wiegand U, Butter C, Zanotto G, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 2007; 28:1835-1840.
6. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, et al. Intrathoracic impedance monitoring in patients with heart failure. Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112:841-848.
7. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A, Rhodes MM. Continuous autonomic assessment in patients with symptomatic heart failure. Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004; 110:2389-2394.
8. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk trial (UK-Heart). Circulation 1998; 98:1510-1516.
9. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003; 108:266-269.
10. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002; 105:2753-2759.
11. Pozzoli M, Cioffi F, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998; 32:197-204.
12. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997; 30:1039-1045.
13. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1570-1573.
14. Buck S, Rienstra M, Maas AH, Nieuwland W, Van Veldhuisen DJ, Van Gelder IC. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace 2008; 10:558-565.
15. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2005; 2:125-131.
16. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in chronic heart failure: electrophysiological and electroanatomical mapping in humans. Circulation 2003; 108:1461-1468.
17. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol 1996; 7:833-842.
18. Chen HH, Schreir RW. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 2006; 119 (12A):S11-S16.
19. Andriulli J. Device monitoring of intrathoracic impedance: clinical observations from a patient registry. Am J Cardiol 2007; 99 (Suppl):23G- 28G.
20. Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M. ACC/AHA 2005 Guidelines update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of cardiology/American Heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Circulation 2005; 112:e154-e235.
21. Ricci RP, Morichelli L, Santini M. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care re source utilization. Europace 2008; 10:164-170.